{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Enveric Biosciences, Inc. "},"Symbol":{"label":"Symbol","value":"ENVB"},"Address":{"label":"Address","value":"4851 TAMIAMI TRAIL N,SUITE 200, NAPLES, Florida, 34103, United States"},"Phone":{"label":"Phone","value":"+1 239 302-1707"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN)."},"CompanyUrl":{"label":"Company Url","value":"https://www.enveric.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jillian Hagel","title":"Chief Technology Officer"},{"name":"Joseph Tucker","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}